We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants
NSPRZ

Delisted

NSPRZ was delisted on the 14th of March, 2022.

Back to rankings

4 hedge funds and large institutions have $63K invested in InspireMD, Inc. Series B Warrants in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

20% less funds holding

Funds holding: 5 → 4 (-1)

36% less capital invested

Capital invested by funds: $99K → $63K (-$36K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.27K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1.21K
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$55K – – –
SM
2
Sabby Management
Florida
$7K -$1.21K -134,681 -7%
UBS Group
3
UBS Group
Switzerland
$1K +$1.27K +141,648 +2,342%

NSPRZ Hedge Fund Activity: Q3 2018 in Review

4 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q3 2018, worth a combined $63K — down 36% from $99K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of NSPRZ and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $1.27K. The largest seller was Sabby Management, cutting an estimated $1.21K.

  • 4 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q3 2018, down from 5 in Q2 2018.
  • Funds reported $63K of InspireMD, Inc. Series B Warrants stock for Q3 2018, down 36% quarter-over-quarter.
  • 0 funds opened new InspireMD, Inc. Series B Warrants positions in Q3 2018 and 1 closed out, a net change of -1 holder.
  • The largest InspireMD, Inc. Series B Warrants buyer in Q3 2018 was UBS Group, an estimated $1.27K added.
  • The largest InspireMD, Inc. Series B Warrants seller in Q3 2018 was Sabby Management, an estimated $1.21K sold.

Based on aggregated 13F filings for Q3 2018.